Live from the NIH registry
Studies recruiting near Warner Robins right now
Top 25 of 74 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Central Georgia Cancer Care — Macon, Georgia (16.9 mi)
· Sponsor: Eli Lilly and Company
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Idiopathic Hypersomnia
Phase 3
Interventional 248 participants sought
Sleep Practitioners, LLC — Macon, Georgia (16.9 mi)
· Sponsor: Harmony Biosciences Management, Inc.
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Atrium Health Navicent — Macon, Georgia (16.9 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Skin Care Physicians Of Georgia — Macon, Georgia (16.9 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
East Coast Institute for Research — Macon, Georgia (16.9 mi)
· Sponsor: Zucara Therapeutics Inc.
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
The Jones Center Clinical Research, LLC — Macon, Georgia (16.9 mi)
· Sponsor: vTv Therapeutics
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Phase 3
Interventional 1,200 participants sought
Gastroenterology Associates of Central Georgia ( Site 5048) — Macon, Georgia (16.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Gastroenterolgy Associates of Central GA — Macon, Georgia (16.9 mi)
· Sponsor: Janssen Research & Development, LLC
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Central Georgia Cancer Care - Macon — Macon, Georgia (16.9 mi)
· Sponsor: Mirati Therapeutics Inc.
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-Small Cell Lung Cancer
Phase 3
Interventional 1,600 participants sought
Central Georgia Cancer Care — Macon, Georgia (16.9 mi)
· Sponsor: Summit Therapeutics
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Untreated Follicular Lymphoma
Phase 3
Interventional 1,018 participants sought
Research Site — Macon, Georgia (16.9 mi)
· Sponsor: AstraZeneca
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
The Jones Center Clinical Research — Macon, Georgia (16.9 mi)
· Sponsor: Amgen
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Atrium Health Navicent — Macon, Georgia (16.9 mi)
· Sponsor: Children's Oncology Group
Intramedullary Calcium Sulfate Antibiotic Depot
Open tíbia Fracture, Osteomyelitis Tibia
Phase 3
Interventional 242 participants sought
Atrium Health Navicent The Medical Center — Macon, Georgia (16.9 mi)
· Sponsor: Wake Forest University Health Sciences
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Pruritus
Phase 3
Interventional 284 participants sought
Skin Care Physicians of Georgia - Macon- Site Number : 8400030 — Macon, Georgia (16.9 mi)
· Sponsor: Sanofi
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Macon, Georgia (16.9 mi)
· Sponsor: Alkermes, Inc.
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
Left-sided Colorectal Cancer
Phase 3
Interventional 960 participants sought
Central Georgia Cancer Care - Warner Robins Office — Warner Robins, Georgia (2.0 mi)
· Sponsor: Genmab
BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial Cancer After Progression on Anti-PD-(L)1-based Therapy
Urothelial Cancer, Metastatic Urothelial Cancer
Phase 3
Interventional 520 participants sought
Central Georgia Cancer Center — Macon, Georgia (16.9 mi)
· Sponsor: SystImmune Inc.
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Atrium Health Navicent — Macon, Georgia (16.9 mi)
· Sponsor: Children's Oncology Group
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Phase 2
Interventional 224 participants sought
Novartis Investigative Site — Macon, Georgia (16.9 mi)
· Sponsor: Novartis Pharmaceuticals
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Crohn's Disease
Phase 2
Interventional 590 participants sought
Gastroenterology Associates of Central Georgia /ID# 265547 — Macon, Georgia (16.9 mi)
· Sponsor: AbbVie
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Gastroenterology Associates of Central Georgia — Macon, Georgia (16.9 mi)
· Sponsor: Hoffmann-La Roche
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2, Phase 3
Interventional 786 participants sought
Alkermes Investigational Site — Macon, Georgia (16.9 mi)
· Sponsor: Alkermes, Inc.
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
Phase 3
Interventional 330 participants sought
Central Georgia Cancer Care PC — Macon, Georgia (16.9 mi)
· Sponsor: Amgen
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Areata Alopecia, Alopecia
Phase 3
Interventional 595 participants sought
Skin Care Physicians of Georgia — Macon, Georgia (16.9 mi)
· Sponsor: Eli Lilly and Company